Founded 2001 Listed on ASX April 2015 - Proteomics International Laboratories Ltd (PILL, ASX: PIQ) Proteomics International is a medical technology company focused on proteomics – the industrial-scale study of the structure and function of proteins. Proteomics International has over 16 years of experience in providing specialist analytical services on a fee-for-service basis . The strength of the company’s research expertise in finding new diagnostic protein biomarkers has also resulted in a ground-breaking predictive test for diabetic kidney disease – PromarkerD. Proteomics International is ISO 17025 accredited and operates in accordance with the OECD Principles of Good Laboratory Practice (GLP). The company was the first laboratory in the world to receive ISO 17025 accreditation for proteomics services. With a continuing focus on quality, Proteomics International is well-equipped to help you with your biosimilars/ biologics, protein analysis, pharmacokinetic testing and biomarker discovery needs. Please see www.proteomics.com.au for more information or contact us at info@proteomics.com.au.